Fudan University
- Country
- 🇨🇳China
- Ownership
- Private
- Established
- 1905-01-01
- Employees
- 1K
- Market Cap
- -
- Website
- http://www.fudan.edu.cn
Phase Ⅱ Study of Neoadjuvant Chemotherapy Followed by Concurrent Chemoradiation for Stage Ⅲ Nasopharyngeal Carcinoma
- First Posted Date
- 2009-01-05
- Last Posted Date
- 2009-01-05
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 52
- Registration Number
- NCT00816855
- Locations
- 🇨🇳
Department of Radiation Oncology, Cancer Hospital, Fudan University, Shanghai, China
Phase Ⅱ Study of Neoadjuvant Chemotherapy Followed by Concurrent Chemoradiation for Stage ⅣAB Nasopharyngeal Carcinoma
- First Posted Date
- 2009-01-05
- Last Posted Date
- 2009-01-05
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 64
- Registration Number
- NCT00816816
- Locations
- 🇨🇳
Department of Radiation Oncology, Cancer Hospital, Fudan University, Shanghai, China
Effectiveness and Safety of Rhubarb for the Treatment of Patients Who Have Suffered From Cerebral Hemorrhage
- First Posted Date
- 2008-12-30
- Last Posted Date
- 2010-05-28
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 100
- Registration Number
- NCT00815737
- Locations
- 🇨🇳
Zhongshan hospital of Fudan University, Shanghai, Shanghai, China
Songyou Granule and Transarterial Chemoembolization for Hepatocellular Carcinoma
- First Posted Date
- 2008-12-10
- Last Posted Date
- 2008-12-31
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 260
- Registration Number
- NCT00805896
- Locations
- 🇨🇳
Cancer Hospital of Fudan University, Shanghai, Shanghai, China
🇨🇳Liver Cancer Institute and Zhongshan Hospital, Shanghai, Shanghai, China
Effectiveness and Safety of Rhubarb for the Treatment of Patients Who Have Suffered From a Stroke
- First Posted Date
- 2008-11-11
- Last Posted Date
- 2010-05-28
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 100
- Registration Number
- NCT00789269
- Locations
- 🇨🇳
Department of Integrative Medicine, Zhongshan hospital, Fudan University, Shanghai, Shanghai, China
C-Reactive Protein (CRP) Gene Variants and Coronary Artery Disease in a Chinese Han Population
- Conditions
- First Posted Date
- 2008-10-27
- Last Posted Date
- 2008-10-27
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 1000
- Registration Number
- NCT00780221
- Locations
- 🇨🇳
Zhongshan Hospital, Shanghai, Shanghai, China
Continuous Infusion of FU Combined With Epirubicin and Oxaliplatin in Patients With A/MGC
- First Posted Date
- 2008-10-07
- Last Posted Date
- 2013-10-16
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 163
- Registration Number
- NCT00767377
- Locations
- 🇨🇳
Fudan University Cancer Hospital, Shanghai, China
Effects of Different Vasodilators on Coronary No-reflow During primAry percuTaneous Coronary intErvention in Patients With Acute Myocardial Infarction
- Conditions
- Interventions
- First Posted Date
- 2008-07-10
- Last Posted Date
- 2012-09-24
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 102
- Registration Number
- NCT00712894
- Locations
- 🇨🇳
Zhongshan Hospital Fudan University, Shanghai, Shanghai, China
Effectiveness and Safety of Xiaoshuanchangrong (XSCR) Capsule for the Treatment of Patients Who Have Suffered From a Stroke
- First Posted Date
- 2008-07-04
- Last Posted Date
- 2010-05-28
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 130
- Registration Number
- NCT00710164
- Locations
- 🇨🇳
Department of Nuerology, The Second People's Hospital of Foshan city, Foshan, Guangdong, China
🇨🇳Department of Nuerology, Kunming General Hospital of Chengdu Military Command, Kunming, Chengdu, China
🇨🇳Department of Nuerology, The Second People's Hospital of Jiangmen city, Jiangmen, Guangdong, China
Study of Cetuximab to Treat Gastric Cancer
- First Posted Date
- 2008-06-18
- Last Posted Date
- 2009-12-23
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 61
- Registration Number
- NCT00699881
- Locations
- 🇨🇳
Fudan University Cancer Hospital, ShangHai, Shanghai, China